| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 64.219 | 96.816 | 117.612 | 167.381 | 130.747 | 177.764 | 191.682 | 156.567 | 200.979 | 192.952 |
| Total Income - EUR | 64.221 | 96.816 | 117.612 | 167.381 | 263.372 | 177.764 | 191.683 | 157.805 | 212.166 | 214.502 |
| Total Expenses - EUR | 31.301 | 36.345 | 26.138 | 41.881 | 152.457 | 47.348 | 48.084 | 45.081 | 74.307 | 181.372 |
| Gross Profit/Loss - EUR | 32.920 | 60.471 | 91.474 | 125.500 | 110.915 | 130.416 | 143.598 | 112.724 | 137.859 | 33.130 |
| Net Profit/Loss - EUR | 30.993 | 59.503 | 90.005 | 123.826 | 108.281 | 128.772 | 141.720 | 111.189 | 135.850 | 26.918 |
| Employees | 4 | 3 | 2 | 2 | 3 | 3 | 3 | 3 | 2 | 2 |
Check the financial reports for the company - Mediprest Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 14.094 | 2.662 | 31.039 | 133.752 | 38.261 | 22.102 | 8.909 | 5.830 | 226.455 | 192.838 |
| Current Assets | 47.149 | 64.677 | 87.432 | 94.010 | 89.697 | 127.723 | 141.333 | 176.065 | 165.605 | 73.329 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 41.879 | 64.197 | 85.983 | 93.610 | 88.966 | 122.670 | 127.995 | 174.620 | 163.810 | 72.569 |
| Cash | 5.271 | 481 | 1.449 | 400 | 731 | 5.052 | 13.337 | 1.445 | 1.795 | 759 |
| Shareholders Funds | 59.355 | 59.557 | 90.058 | 123.878 | 108.331 | 128.822 | 141.768 | 111.238 | 135.899 | 26.966 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.888 | 7.782 | 28.414 | 103.884 | 19.627 | 21.003 | 8.473 | 70.657 | 85.000 | 90.367 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 171.162 | 148.834 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Mediprest Srl